首页> 外文期刊>Health services research: HSR >Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States
【24h】

Disparities in use of gynecologic oncologists for women with ovarian cancer in the United States

机译:在美国,妇科肿瘤科医生对卵巢癌女性的使用差异

获取原文
获取原文并翻译 | 示例
           

摘要

Objective To examine disparities in utilization of gynecologic oncologists (GOs) across race and other sociodemographic factors for women with ovarian cancer. Data Sources Obtained SEER-Medicare linked dataset for 4,233 non-Hispanic White, non-Hispanic African American, Hispanic of any race, and Non-Hispanic Asian women aged ≥66 years old diagnosed with ovarian cancer during 2000-2002 from 17 SEER registries. Physician specialty was identified by linking data to the AMA master file using Unique Physician Identification Numbers. Study Design Retrospective claims data analysis for 1999-2006. Logistic regression models were used to analyze the association between GO utilization and race/ethnicity in the initial, continuing, and final phases of care. Principal Findings GO use decreased from the initial to final phase of care (51.4-28.8 percent). No racial/ethnic differences were found overall and by phase of cancer care. Women >70 years old and those with unstaged disease were less likely to receive GO care compared to their counterparts. GO use was lower in some SEER registries compared to the Atlanta registry. Conclusions GO use for the initial ovarian cancer treatment or for longer term care was low but not different across racial/ethnic groups. Future research should identify factors that affect GO utilization and understand why use of these specialists remains low.
机译:目的探讨卵巢癌妇女跨种族和其他社会人口统计学因素的妇科肿瘤科医生(GOs)使用率差异。数据源在2000-2002年期间从17个SEER注册管理机构中获得了4,233名非西班牙裔白人,非西班牙裔非裔美国人,任何种族的西班牙裔和66岁以上的非西班牙裔亚裔妇女的SEER-Medicare链接数据集。通过使用唯一医师识别码将数据链接到AMA主文件来识别医师专长。研究设计回顾性索赔数据分析为1999-2006年。 Logistic回归模型用于分析初始,持续和最终阶段的GO利用率与种族/种族之间的关联。主要调查结果GO的使用从护理的初始阶段到最终阶段减少了(51.4-28.8%)。在癌症治疗的总体和阶段中,未发现种族/种族差异。与同龄女性相比,> 70岁的女性和未分阶段疾病的女性接受GO护理的可能性较小。与亚特兰大注册处相比,某些SEER注册处的GO使用率更低。结论GO在最初的卵巢癌治疗或长期护理中的使用率较低,但在种族/族裔人群之间没有差异。未来的研究应确定影响GO利用率的因素,并了解为何这些专家的使用率仍然很低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号